Biblio Discovery — Demo Discovery Service

9 results for "Mar Guasp"

Showing 1–9 · 1.35 seconds · RSS

  1. Journal Article

    Autoimmune neuropsychiatric disorders manifesting with psychosis

    José Maria Cabrera-Maqueda; Jesús Planagumà; Mar Guasp et al.

    The Journal of Clinical Investigation, Vol. 135 No. 20 · 2025 · English · DOAJ Scopus

    The increasing recognition of a new category of encephalitides that occur in association with antibodies against neuronal surface proteins has prompted the use of terms like “autoimmune psychosis” and “autoimmune psychiatric disorders.” However, although psychosis and other psychiatric symptoms can…

  2. Journal Article

    The diagnosis of anti-LGI1 encephalitis varies with the type of immunodetection assay and sample examined

    Guillermo Muñoz-Sánchez; Jesús Planagumà; Laura Naranjo et al.

    Frontiers in Immunology, Vol. 13 · 2022 · English · DOAJ Scopus

    Detection of Leucine-rich glioma inactivated 1 (LGI1) antibodies in patients with suspected autoimmune encephalitis is important for diagnostic confirmation and prompt implementation of immunomodulatory treatment. However, the clinical laboratory diagnosis can be challenging. Previous reports have…

  3. Journal Article

    Limitations of a Commercial Assay as Diagnostic Test of Autoimmune Encephalitis

    Raquel Ruiz-García; Guillermo Muñoz-Sánchez; Laura Naranjo et al.

    Frontiers in Immunology, Vol. 12 · 2021 · English · DOAJ Scopus

    Detection of neuronal surface antibodies (NSAb) is important for the diagnosis of autoimmune encephalitis (AE). Although most clinical laboratories use a commercial diagnostic kit (Euroimmun, Lübeck, Germany) based on indirect immunofluorescence on transfected cells (IIFA), clinical experience…

  4. Journal Article

    Evidence of neurophysiological improvement of early manifestations of small-fiber dysfunction after liver transplantation in a patient with familial amyloid neuropathy

    Mar Guasp; Alejandro A. Köhler; Michela Campolo et al.

    Clinical Neurophysiology Practice, Vol. 3 · 2018 · English · DOAJ Scopus

    Introduction: Small fiber polyneuropathy (SFP) is a common heralding clinical manifestation of damage to the nervous system in patients with familial amyloidosis. The diagnosis of SFP is a significant factor in the decision to treat a previously asymptomatic gene carrier, as treatment would prevent…

  5. Journal Article

    CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome

    Mar Guasp; Guillermo Muñoz-Sánchez; Eugenia Martínez-Hernández et al.

    Frontiers in Immunology, Vol. 13 · 2022 · English · DOAJ Scopus

    Patients with coronavirus disease 2019 (COVID-19) frequently develop acute encephalopathy and encephalitis, but whether these complications are the result from viral-induced cytokine storm syndrome or anti-neural autoimmunity is still unclear. In this study, we aimed to evaluate the diagnostic and…

  6. Journal Article

    Cycloid psychosis as a psychiatric expression of anti‐NMDAR encephalitis. A systematic review of case reports accomplished with the authors' cooperation

    Eloi Giné Servén; Ester Boix Quintana; Maria Martínez Ramírez et al.

    Brain and Behavior, Vol. 11 No. 2 · 2021 · English · DOAJ Scopus

    Abstract Objective We reviewed the psychotic symptoms of anti‐NMDA receptor encephalitis (NMDARE) to differentiate its presentation from those found in a primary psychiatric disorder. We hypothesized that the cycloid psychosis (CP) phenotype would be a frequent clinical presentation in the…

  7. Journal Article

    Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective study

    Juan Luis Chico-Garcia; Moisés Morales de la Prida; Almudena Boix Lago et al.

    Therapeutic Advances in Neurological Disorders, Vol. 19 · 2026 · English · DOAJ Scopus

    Background: Plasma exchange (PE) is a therapeutic option for CNS demyelinating attacks unresponsive to corticosteroids, but the potential benefit of adding rituximab and IV immunoglobulins to PE (RTX-IVIG-PE), which has shown its efficacy and safety in other immune-mediated conditions, has not been…

  8. Journal Article

    Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort studyResearch in context

    Juliette Brenner; Anna E.M. Bastiaansen; Mar Guasp et al.

    The Lancet Regional Health. Europe, Vol. 62 · 2026 · English · DOAJ Scopus

    Summary: Background: Anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis is a severe disease that primarily affects young people and can improve with adequate treatment. We aimed to refine the anti-NMDAR Encephalitis One-year functional Status (NEOS) score by developing NEOS2, an updated…